Naperville, IL -- (SBWire) -- 06/05/2012 --The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis, arrhythmias, hypertension, peripheral and cerebral vascular diseases, and hematologic disorders provides a competitor evaluation in the field of R&D projects with cardiovascular peptides as of December 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of current active projects in research and development of cardiovasuclar peptides. In addition, the report lists company-specific R&D pipelines of cardiovascular peptides. Competitor projects are listed in a tabular format providing information on:

Drug Codes,
Target / Mechanism of Action,
Class of Compound,
Company,
Product category,
Indication,
R&D Stage and
additional comments with a hyperlink leading to the source of information.

To view the detailed table of contents for this report please visit: http://www.reportstack.com/product/79159/cardiovascular-peptides-competitor-analysis.html